Paladin Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$812K Buy
677
+188
+38% +$192K 0.47% 64
2026
Q1
$450K Sell
489
-52
-10% -$52.7K 0.31% 93
2025
Q4
$581K Buy
+541
New +$517K 0.4% 84

Other funds holding LLY

Paladin Wealth's LLY Position: Q2 2026 in Review

Paladin Wealth increased its Eli Lilly (LLY) stake by 38% in Q2 2026, buying an estimated $192K and bringing the position to 677 shares worth $812K. The position accounts for 0.47% of the portfolio, ranked #64.

Paladin Wealth first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Paladin Wealth held 677 shares of Eli Lilly worth $812K as of Q2 2026.
  • Paladin Wealth bought 188 Eli Lilly shares in Q2 2026, an estimated $192K.
  • Eli Lilly made up 0.47% of Paladin Wealth's portfolio in Q2 2026, its #64 holding.
  • Paladin Wealth first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Paladin Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.